CAS No. |
103213-49-6 |
|---|---|
中文名称 |
(2S,5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,41S)-41-氨基-26,32-双(2-氨基-2-氧代乙基)-11,14-二苄基-20,23-双(2-羧基乙基)-29-(羧甲基)-2-(3-胍基丙基)-8-(羟甲基)-35-异丙基-5-甲基-4,7,10,13,16,19,22,25,28,31,34,37,40-十三氧代-3,6,9,12,15,18,21,24,27,30,33,36,39-十三氮杂四十四烷二酸 |
英文名称 |
(2S,5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,41S)-41-amino-26,32-bis(2-amino-2-oxoethyl)-11,14-dibenzyl-20,23-bis(2-carboxyethyl)-29-(carboxymethyl)-2-(3-guanidinopropyl)-8-(hydroxymethyl)-35-isopropyl-5-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazatetratetracontanedioic acid |
别名 |
GLU-GLY-VAL-ASN-ASP-ASN-GLU-GLU-GLY-PHE-PHE-SER-ALA-ARG;GLU-GLY-VAL-ASN-ASP-ASN-GLU-GLU-GLY-PHE-SER-ALA-ARG;(GLU1)-FIBRINOPEPTIDE B;[GLU1]-FIBRINOPEPTIDE B HUMAN;H-GLU-GLY-VAL-ASN-ASP-ASN-GLU-GLU-GLY-PHE-PHE-SER-ALA-ARG-OH;FGB;Fibrinogen beta chain;Monoclonal Anti-FGB antibody produced in mouse |
标准英文名 |
(2S,5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,41S)-41-amino-26,32-bis(2-amino-2-oxoethyl)-11,14-dibenzyl-20,23-bis(2-carboxyethyl)-29-(carboxymethyl)-2-(3-guanidinopropyl)-8-(hydroxymethyl)-35-isopropyl-5-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazatetratetracontanedioic acid |
MDL No. |
MFCD00076440 |
分子式 |
C66H95N19O26 |
分子量 |
1570.59 |
精确分子量 |
1569.67 |
SMILES |
CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O |
标准SMILES |
CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
用途 |
Stimulates neutrophils (PMNs), monocytes, and fibroblasts; induces directed cell migration (chemotaxis) of PMNs and fibroblasts with optimal activity at approximately 10 nM; promotes rapid, dose-dependent increase in PMN cytoskeletal-associated actin; recruits PMNs and fibroblasts to sites of fibrin deposition and turnover; induces PMN chemotaxis without triggering lysosomal enzyme release (e.g., lysozyme and beta-glucuronidase) or superoxide anion production. |
InChIKey |
KPBJTGOVJLITON-OECXYHNASA-N |
|
|
评论 |
|---|